Abstract #3905

A pilot study of 18F-PSMA PET/CT or PET/MRI and ultrasound fusion targeted prostate biopsy for intra-prostatic PET-positive lesions

Yachao Liu¹, Hongkai Yu², Jiajin Liu¹, Xiaojun Zhang¹, Mu Lin³, Holger Schmidt⁴, Jiangping Gao², and Baixuan Xu¹

¹Department of Nuclear Medicine, Chinese PLA General Hospital, Beijing, China, ²Department of Urology Surgery, Chinese PLA General Hospital, Beijing, China, ³MR collaborations, Diagnostic Imaging, Siemens Healthcare, Shanghai, China, ⁴MR Education, Customer Services, Siemens Healthcare, Erlangen, Germany

The purpose of this study is to evaluate the feasibility and diagnostic performance of ¹⁸F-PSMA PET/CT-ultrasound (PET/CT-US) or PET/MRI-ultrasound (PET/MRI-US) fusion targeted biopsy for intra-prostatic PET-positive lesions. 55 candidates were prospectively enrolled for PET/CT-US or PET/MRI-US fusion targeted biopsies at solitary PET-positive lesions. A total of 178 core biopsies were performed on 55 patients. 146 biopsy cores (82.0%, 146/178) from 51 (92.7%, 51/55) patients were positive for prostate cancer; 47 (85.5%, 47/55) were clinically significant prostate cancer. 18F-PSMA PET/CT-US or PET/MRI-US fusion-targeted prostate biopsy are feasible for prostate cancer diagnosis and has high detection rate of clinically significant prostate cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.